Still, 512% of participants discontinued the drug, and the rate was higher at maximum doses
Suspected adverse reactions to any unlicensed compound should be reported to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk
In contrast, many insurance plans cover FDA-approved Ozempic when prescribed for approved indications, though prior authorization may be required
Most of the grey market buyers Reuters interviewed had told their medical providers they were taking GLP-1 medicines but not where or how they bought them
In the private insurance market, 57.4 million adults under 65 could be potentially eligible for GLP-1 drugs Over 2 in 5 (42%) adults under 65 with private insurance could be eligible for GLP-1 drugs, based on current Food and Drug Administration (FDA) indications
Wegovy : Up to 28 days at room temperature after first use